Stock Information
Intellia Therapeutics Inc (NTLA)
Ticker Symbol: NTLA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,780.06 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.36
Revenue (TTM): $0.45 M
Dividend Yield: N/A
ROE: -57.79%
Latest News
-
Could This Cathie Wood Stock Soar in 2027?
Sun, Sep 27, 2026 4:50 PM
-
Intellia Therapeutics Bears Growl Again, This Time About Claude AI -- Yawn!
Sun, Sep 27, 2026 4:49 AM
-
Prime: A Buy Due To BLA Filing H1 '27 And Continued PM647 Advancement
Fri, Sep 25, 2026 4:00 PM
-
Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing
Thu, Sep 24, 2026 2:59 PM
-
Anthropic AI Discovery Gene-Editing Stocks Falling
Thu, Sep 24, 2026 12:46 PM
-
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
Wed, Sep 23, 2026 9:49 PM
-
CRISPR Therapeutics Traded Sideways and Down for 12 Months: One Wall Street Pro Expects 85% Gains Soon
Wed, Sep 23, 2026 12:22 PM
-
Intellia Therapeutics (NTLA) Stock Gets FDA Priority Review For Lonvo Z Gene Editing Therapy
Tue, Sep 22, 2026 1:20 PM
Key Financials
Financial data not available
